[WS(P)29] Cell therapy, vaccine, and new therapeutic modality

[WS29-21-P] Peptide immunotherapy targeting FAP-positive fibroblasts

^○Keiko Udaka¹, Taro Komatsu¹, Yuki Tanaka², Kousuke Onoue², Yoshiko Yamashita², Kazuhide Onoguchi², Ryo Tanaka³, Yoichiro Iwase³, Naoki Sakaguchi^3,4 (1.Department of Immunology, School of Medicine, Kochi University, 2.Division of AI Drug Development, NEC Corporation, 3.Pharmaceutical Solutions Division, R&D, TERUMO Corporation, 4.previous affiliation)

キーワード：

peptide、immunotherapy、MHC、tumor、T cell

閲覧にはパスワードが必要です

ログイン

または